Real-time enrollment status for this sjögren´s disease clinical trial
Current Status
Recruiting
Checked: August 19, 2026 at 6:58 PM UTC
| NCT Number | NCT07621809 |
| Recruiting Status | Recruiting |
| Condition | Sjögren´s Disease |
| Phase | PHASE3 |
| Target Enrollment | 570 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 18, 2026 (Yesterday) |
As of August 19, 2026: Clinical trial NCT07621809 is currently recruiting participants. This phase3 study for sjögren´s disease is actively seeking new participants at 12 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07621809 is actively recruiting participants as of August 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07621809 was last updated Yesterday (August 18, 2026). HelloStudys verifies this status automatically.